Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.This is an entirely free service. No payments are to be made.
|Live BSE Quotes||Mar 28, 2017 (Close)|
|Price (Rs)1,136.70||Open (Rs) 1,133.00||High (Rs) 1,144.00||Low (Rs) 1,128.00|
|% Change0.30||Volume 17,069||Value (Rs) 19,398,457||52-Week H/L 1,150.00 / 472.60|
|Live NSE Quotes||Mar 28, 2017 (Close)|
|Price (Rs)1,140.25||Open (Rs) 1,141.90||High (Rs) 1,145.00||Low (Rs) 1,127.40|
|% Change0.69||Volume 271,864||Value (Rs) 309,025,597||52-Week H/L 1,152.15 / 475.35|
|EPS (Rs)* 28.86||P/E Ratio (x) 39.39||Market Cap (Rs m) 227,340.00||P/BV (x) 5.61|
|*Trailing 12 months earnings, excluding extraordinary / exceptional items.||BSE Sensex | CNX Nifty|
|Biocon Ltd Share Price Chart (Rs) - 1 Year|
Quote & Graph
S&P BSE SENSEX
Indian share markets continued to witness buying momentum in the afternoon session. At the closing bell, the BSE Sensex stood higher by 172 points, while the NSE Nifty finished up by 56 points.
Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.
Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.
Biocon has announced its 4QFY16 and full year results. The company has reported 16.8% YoY growth in total income and 79.1% YoY increase in net profits. Here is our analysis of the results.
Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.
Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.More Views on News
The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.
Digital transactions have fallen since December 2016 both in value and volume terms.
Apurva breaks down the historic performance of initial public offerings in the context of D-Mart.
Markets are moving up even after the fed interest rate hike.
PersonalFN provides a prudent investment strategy to invest in mutual funds as market scales a new high.More